Simplex Trading, LLC Akero Therapeutics, Inc. Transaction History
Simplex Trading, LLC
- $156 Billion
- Q1 2025
A detailed history of Simplex Trading, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 40,853 shares of AKRO stock, worth $2.21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,853
Previous 22,855
78.75%
Holding current value
$2.21 Million
Previous $635,000
160.31%
% of portfolio
0.0%
Previous 0.02%
Shares
15 transactions
Others Institutions Holding AKRO
# of Institutions
270Shares Held
86MCall Options Held
1.02MPut Options Held
823K-
Rtw Investments, LP New York, NY7.42MShares$401 Million4.92% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$382 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$321 Million0.05% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$302 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$283 Million7.15% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.51B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...